Low adherence rates for prostate cancer quality of care measures

April 21, 2014
Low adherence rates for prostate cancer quality of care measures

(HealthDay)—Adherence to established prostate cancer quality of care measures is frequently low, with considerable regional variation, according to a study published in the April issue of The Journal of Urology.

Florian R. Schroeck, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a retrospective study to examine in to quality measures for 53,614 patients with newly diagnosed . Patients were identified from Surveillance, Epidemiology, and End Results-Medicare data for 2001 to 2007, and were assigned to 661 regions.

The researchers observed extensive patient-level variation in adherence, varying from 33 percent for treatment by a high-volume provider to 76 percent for adjuvant androgen deprivation therapy receipt while undergoing radiation for high-risk cancer. Considerable regional variation was observed in adherence to several measures, including pretherapy counseling by a urologist and radiation oncologist, which ranged from 9 to 89 percent; avoiding bone scan overuse in low-risk cancer, which ranged from 16 to 96 percent; treatment by a high-volume provider, which ranged from 1 to 90 percent; and follow-up with a , which varied from 14 to 86 percent (all P < 0.001).

"We found low adherence rates for most established prostate cancer quality of care measures. Within most measures regional variation in adherence was pronounced," the authors write. "Measures with low adherence and a large amount of regional variation may be important low hanging targets for quality improvement."

One author disclosed financial ties to Amgen; one author disclosed financial ties to Elsevier.

Explore further: Medicare spending for advanced cancer not linked to survival differences

More information: Abstract
Full Text

Related Stories

Lifestyle factors linked to less aggressive prostate cancer

July 22, 2013

(HealthDay)—Adherence to lifestyle recommendations intended to reduce the risk of cancer generally is associated with a lower risk of highly aggressive prostate cancer in men newly diagnosed with the disease, according ...

Patients prefer specific info from docs for prostate cancer

March 11, 2014

(HealthDay)—Although patients with prostate cancer endorse multiple sources of information, they report greatest satisfaction with information from the treating physician about patient outcomes, according to research to ...

Info, motivation, behavioral skill affect med adherence

March 12, 2014

(HealthDay)—Patients' adherence-related information, motivation, and behavioral skills (IMB) are important targets for interventions promoting adherence to diabetes medications, according to a study published online March ...

Considerable variation in CT use in ischemic stroke

April 17, 2014

(HealthDay)—For patients with ischemic stroke there is considerable variation in the rates of high-intensity computed tomography (CT) use, according to a study published online April 8 in Circulation: Cardiovascular Quality ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.